AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 253.91B, AstraZeneca(AZN) trades at $163.72. The stock has a price-to-earnings ratio of 23.77 and currently yields dividends of 1.68%.
On 2026-09-14, AstraZeneca(AZN) stock moved within a range of $162.14 to $164.53. With shares now at $163.72, the stock is trading +1.0% above its intraday low and -0.5% below the session's peak.
Trading activity shows a volume of 2.51M, compared to an average daily volume of 3.15M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new safety study tracks long-term use of eplontersen in patients wi...
AstraZeneca Plc (NYSE:AZN) reported updated clinical outcomes across its oncology portfolio, demonstrating sustained long-term survival advantages in lung cance...
Analyst Sachin Jain from Bank of America Securities maintained a Buy rating on AstraZeneca and keeping the price target at p16,500.00. Sachin Jain has given hi...
Analyst ratings
100%
of 10 ratingsMore AZN News
Stifel lowered the firm’s price target on Olema Oncology (OLMA) to $30 from $48 and keeps a Buy rating on the shares after AstraZeneca (AZN) announced on Friday...
Results from the DESTINY-Lung04 Phase III trial showed AstraZeneca (AZN) and Daiichi Sankyo’s Enhertu demonstrated a statistically significant and clinically me...
...
(RTTNews) - AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) said the SERENA-4 Phase III trial of Etcamah or camizestrant in combination with palbociclib did not meet t...
AstraZeneca continues to study the pill in other trials, both as standalone therapy and in combination with other drugs. Rachel Wisniewski / Reuters AstraZenec...
Astrazeneca (NYSE:AZN) presented Phase III data for tozorakimab in chronic obstructive pulmonary disease, or COPD, at the 2026 European Respiratory Society Cong...
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? 8/27/2026 Amgen and AstraZeneca's drug, Tezspire, scored Thursday in an esophageal disease t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.